1 / 6

Electronic Drug Delivery Systems Market 2020-2025 Size, Current Trends, Health Benefits, Key Players, Regional Overview

Increase in prevalence of target diseases including diabetes, asthma, chronic obstructive pulmonary disorder (COPD), and cardiovascular diseases coupled with rapid technological advancements in drug delivery devices are key factors driving the global electronic drug delivery systems market.

Download Presentation

Electronic Drug Delivery Systems Market 2020-2025 Size, Current Trends, Health Benefits, Key Players, Regional Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Adroit Market Research Electronic Drug Delivery Systems Electronic Drug Delivery Systems Market Market Size 2018, By Product Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens, Electronic Inhalers), Application (Cardiovascular Diseases, Multiple Sclerosis, Diabetes, Asthma & COPD, Others), Region and Forecast 2019 to 2025 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research Global Electronic Drug Delivery Systems Market Is Expected To Witness An Lucrative Global Electronic Drug Delivery Systems Market Is Expected To Witness An Lucrative Growth With A CAGR Of 7.9% Over The Forecast Period Growth With A CAGR Of 7.9% Over The Forecast Period The global electronic drug delivery systems market is projected to reach an approximate value of USD 11.7 billion by 2025, growing at a CAGR of 7.9%. Increasing prevalence of diabetes and other chronic disorders such as cardiovascular diseases, COPD, asthma, and multiple sclerosis, rapidly growing geriatric population, favorable reimbursement scenario in developed regions are factors driving the electronic drug delivery systems market. Adroit Market Research report on global electronic drug delivery systems market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global electronic drug delivery systems market have been studied in detail. Rapidly increasing target diseases such as diabetes, cardiovascular diseases, asthma, chronic obstructive pulmonary disorder, multiple sclerosis is likely to fuel the demand for electronic drug delivery systems in the coming few years. Increase in geriatric patient pool susceptible to cardiovascular and respiratory disorders along with rapid technological advancements such as launch of integrated technologies is expected for robust market expansion in the coming few years. Moreover, favorable reimbursement scenario in developed regions is anticipated to fuel the growth of the market in the future. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research Global Electronic Drug Delivery Systems Market Is Expected To Witness An Lucrative Global Electronic Drug Delivery Systems Market Is Expected To Witness An Lucrative Growth With A CAGR Of 7.9% Over The Forecast Period Growth With A CAGR Of 7.9% Over The Forecast Period North America dominated the global electronic drug delivery systems market in 2018. High prevalence of target diseases including diabetes and cardiovascular diseases, greater adoption of advanced drug delivery systems, increase in expenditure on diabetes care, presence of large geriatric population and favorable reimbursement scenario in the region are key factors likely to drive the growth of the market in the next few years. According to International Diabetes Federation (IDF), a total of 301,700 deaths were attributable to diabetes in 2019. Also, approximately, 325 billion was spent on diabetes in North America. However, Asia Pacific electronic drug delivery systems market is anticipated to grow at a rapid pace over the forecast period. Major players operating in the global electronic drug delivery systems market include Insulet Corporation, Medtronic plc, Merck Group, United Therapeutics Corporation, Novo Nordisk, Bayer AG, AstraZeneca, Amgen, Tandem Diabetes Care, and Phillips-Medisize among others. Browse the complete report on @ https://www.adroitmarketresearch.com/industry-reports/electronic-drug- delivery-systems-market +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research Segment Overview of Global Electronic Drug Delivery Segment Overview of Global Electronic Drug Delivery Systems Market Systems Market Product Type Overview, 2015-2025 (USD Million) • Electronic Wearable Infusion Pumps • Electronic Autoinjectors • Electronic Injection Pens • Electronic Inhalers Application Overview, 2015-2025 (USD Million) • Cardiovascular Diseases • Asthma & COPD • Diabetes • Multiple Sclerosis • Others +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research Segment Overview of Global Electronic Drug Delivery Segment Overview of Global Electronic Drug Delivery Systems Market Systems Market Regional Overview, 2015-2025 (USD Million) • North America • Europe • Asia Pacific • South America • Middle East & Africa Purchase a single user copy of the global Electronic Drug Delivery Systems Market report@ https://www.adroitmarketresearch.com/researchreport/purchase/1490 +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  6. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and manymore. Contact Us US Headquarters Phone: +1 (214) 884-6068 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related